Latest in Fda's
Sort by
6 items
-
FDA’s Food Safety Chief Resigns
The chief said the loss of critical employees overseeing the nation’s food supply made his work impossible. Robert F. Kennedy Jr., the nation’s new health secretary, has pledged to gut the division.The New York Times - 2d -
FDA declares end to Wegovy and Ozempic shortage
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.CBS News - 1h -
Top FDA official resigns, warns firings will backfire on RFK Jr.
James Jones resigned as FDA deputy commissioner and said the Trump administration's "indiscriminate" job cuts show "disdain for the very people necessary to implement your agenda."CBS News - 16h -
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.CNBC - 1h -
Firings at FDA Decimated Teams for AI and Food Safety. Those Hires Are Now Gone.
Teams evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though industry fees, not taxpayers, financed the employee salaries.The New York Times - 49m -
Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage
Shares of Hims & Hers tumble 21% after FDA says semaglutide is no longer in shortageCNBC - 22m